STOCKHOLM, OCTOBER 30th, 2019. Moberg Pharma AB (publ)’s (“Moberg Pharma” or the “Company”) Annual General Meeting took place today in the Company’s premises in Bromma. The Annual General Meeting resolved in accordance with the Nomination Committee’s and Board of Directors’ proposals, including a payment to the shareholders of SEK 46.50 for each existing ordinary share.
Adoption of the income statements and the balance sheets
The Annual General Meeting approved the income statements and the balance sheets for the abbreviated financial year 2019.
The Annual General Meeting resolved, in